_version_ 1784764313722945536
author Sánchez, Lina
Vidal, Marta
Jairoce, Chenjerai
Aguilar, Ruth
Ubillos, Itziar
Cuamba, Inocencia
Nhabomba, Augusto J.
Williams, Nana Aba
Díez-Padrisa, Núria
Cavanagh, David
Angov, Evelina
Coppel, Ross L.
Gaur, Deepak
Beeson, James G.
Dutta, Sheetij
Aide, Pedro
Campo, Joseph J.
Moncunill, Gemma
Dobaño, Carlota
author_facet Sánchez, Lina
Vidal, Marta
Jairoce, Chenjerai
Aguilar, Ruth
Ubillos, Itziar
Cuamba, Inocencia
Nhabomba, Augusto J.
Williams, Nana Aba
Díez-Padrisa, Núria
Cavanagh, David
Angov, Evelina
Coppel, Ross L.
Gaur, Deepak
Beeson, James G.
Dutta, Sheetij
Aide, Pedro
Campo, Joseph J.
Moncunill, Gemma
Dobaño, Carlota
author_sort Sánchez, Lina
collection PubMed
description
format Online
Article
Text
id pubmed-9360401
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-93604012022-08-10 Author Correction: Antibody responses to the RTS,S/AS01(E) vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique Sánchez, Lina Vidal, Marta Jairoce, Chenjerai Aguilar, Ruth Ubillos, Itziar Cuamba, Inocencia Nhabomba, Augusto J. Williams, Nana Aba Díez-Padrisa, Núria Cavanagh, David Angov, Evelina Coppel, Ross L. Gaur, Deepak Beeson, James G. Dutta, Sheetij Aide, Pedro Campo, Joseph J. Moncunill, Gemma Dobaño, Carlota NPJ Vaccines Author Correction Nature Publishing Group UK 2022-08-08 /pmc/articles/PMC9360401/ /pubmed/35941348 http://dx.doi.org/10.1038/s41541-022-00515-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Author Correction
Sánchez, Lina
Vidal, Marta
Jairoce, Chenjerai
Aguilar, Ruth
Ubillos, Itziar
Cuamba, Inocencia
Nhabomba, Augusto J.
Williams, Nana Aba
Díez-Padrisa, Núria
Cavanagh, David
Angov, Evelina
Coppel, Ross L.
Gaur, Deepak
Beeson, James G.
Dutta, Sheetij
Aide, Pedro
Campo, Joseph J.
Moncunill, Gemma
Dobaño, Carlota
Author Correction: Antibody responses to the RTS,S/AS01(E) vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique
title Author Correction: Antibody responses to the RTS,S/AS01(E) vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique
title_full Author Correction: Antibody responses to the RTS,S/AS01(E) vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique
title_fullStr Author Correction: Antibody responses to the RTS,S/AS01(E) vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique
title_full_unstemmed Author Correction: Antibody responses to the RTS,S/AS01(E) vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique
title_short Author Correction: Antibody responses to the RTS,S/AS01(E) vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique
title_sort author correction: antibody responses to the rts,s/as01(e) vaccine and plasmodium falciparum antigens after a booster dose within the phase 3 trial in mozambique
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360401/
https://www.ncbi.nlm.nih.gov/pubmed/35941348
http://dx.doi.org/10.1038/s41541-022-00515-8
work_keys_str_mv AT sanchezlina authorcorrectionantibodyresponsestothertssas01evaccineandplasmodiumfalciparumantigensafteraboosterdosewithinthephase3trialinmozambique
AT vidalmarta authorcorrectionantibodyresponsestothertssas01evaccineandplasmodiumfalciparumantigensafteraboosterdosewithinthephase3trialinmozambique
AT jairocechenjerai authorcorrectionantibodyresponsestothertssas01evaccineandplasmodiumfalciparumantigensafteraboosterdosewithinthephase3trialinmozambique
AT aguilarruth authorcorrectionantibodyresponsestothertssas01evaccineandplasmodiumfalciparumantigensafteraboosterdosewithinthephase3trialinmozambique
AT ubillositziar authorcorrectionantibodyresponsestothertssas01evaccineandplasmodiumfalciparumantigensafteraboosterdosewithinthephase3trialinmozambique
AT cuambainocencia authorcorrectionantibodyresponsestothertssas01evaccineandplasmodiumfalciparumantigensafteraboosterdosewithinthephase3trialinmozambique
AT nhabombaaugustoj authorcorrectionantibodyresponsestothertssas01evaccineandplasmodiumfalciparumantigensafteraboosterdosewithinthephase3trialinmozambique
AT williamsnanaaba authorcorrectionantibodyresponsestothertssas01evaccineandplasmodiumfalciparumantigensafteraboosterdosewithinthephase3trialinmozambique
AT diezpadrisanuria authorcorrectionantibodyresponsestothertssas01evaccineandplasmodiumfalciparumantigensafteraboosterdosewithinthephase3trialinmozambique
AT cavanaghdavid authorcorrectionantibodyresponsestothertssas01evaccineandplasmodiumfalciparumantigensafteraboosterdosewithinthephase3trialinmozambique
AT angovevelina authorcorrectionantibodyresponsestothertssas01evaccineandplasmodiumfalciparumantigensafteraboosterdosewithinthephase3trialinmozambique
AT coppelrossl authorcorrectionantibodyresponsestothertssas01evaccineandplasmodiumfalciparumantigensafteraboosterdosewithinthephase3trialinmozambique
AT gaurdeepak authorcorrectionantibodyresponsestothertssas01evaccineandplasmodiumfalciparumantigensafteraboosterdosewithinthephase3trialinmozambique
AT beesonjamesg authorcorrectionantibodyresponsestothertssas01evaccineandplasmodiumfalciparumantigensafteraboosterdosewithinthephase3trialinmozambique
AT duttasheetij authorcorrectionantibodyresponsestothertssas01evaccineandplasmodiumfalciparumantigensafteraboosterdosewithinthephase3trialinmozambique
AT aidepedro authorcorrectionantibodyresponsestothertssas01evaccineandplasmodiumfalciparumantigensafteraboosterdosewithinthephase3trialinmozambique
AT campojosephj authorcorrectionantibodyresponsestothertssas01evaccineandplasmodiumfalciparumantigensafteraboosterdosewithinthephase3trialinmozambique
AT moncunillgemma authorcorrectionantibodyresponsestothertssas01evaccineandplasmodiumfalciparumantigensafteraboosterdosewithinthephase3trialinmozambique
AT dobanocarlota authorcorrectionantibodyresponsestothertssas01evaccineandplasmodiumfalciparumantigensafteraboosterdosewithinthephase3trialinmozambique